Evid Invest

Earnings calendar/LFCR

LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.

Latest filed quarter

The most recent quarter LIFECORE BIOMEDICAL, INC. \DE\ has filed, from EvidInvest's standardized statements.

Period end

Dec 31, 2026

Q4 FY2026

Filed

Mar 16, 2026

Filing date on record

EPS (diluted)

$-0.19

No estimate on record

Revenue

$34.2M

As filed

Net income

$-6.2M

As filed

EPS YoY

-216.7%

vs quarter ended 2025-05-25

Revenue YoY

-6.2%

vs quarter ended 2025-05-25

Next report

Nov 5, 2026

Estimated from filing cadence, ± 3 days

Run-rate

Trailing twelve months, summed from the last four filed quarters.

TTM EPS (diluted)

$-0.77

2025-12-31 through 2026-12-31

TTM revenue

$122.3M

2025-12-31 through 2026-12-31

Filed quarters

40

On record here

EPS at or above estimate (4Q)

75%

Of the last four quarters that carry an estimate

Filed quarters

One row per filed statement, newest first

Period endFiledEPS dilutedRevenueEPS YoYRevenue YoYEst. EPSSurprise
2026-12-31Q4 FY20262026-03-16$-0.19$34.2M-216.7%-6.2%——
2026-06-30Q4 FY20262026-08-05$-0.19$34.2M-216.7%-6.2%$-0.190.0%
2026-03-31Q3 FY20262026-05-06$-0.43$23.2M-2.4%-34.0%$-0.27-59.3%
2025-12-31Q4 FY20262026-03-16$0.04$30.8M+166.7%-15.6%$-0.29+113.8%
2025-09-30Q1 FY20262025-11-06$-0.29$31.1M+45.3%+25.9%$-0.30+3.3%
2025-05-25Q4 FY20252026-08-05$-0.06$36.4M+53.8%-3.8%$-0.09+33.3%
2025-02-23Q3 FY20252025-04-03$-0.42$35.2M-200.0%-1.5%$-0.14-200.0%
2024-11-24Q2 FY20252025-01-02$-0.25$32.6M-164.1%+8.0%$-0.27+7.4%
2024-08-25Q1 FY20252024-10-04$-0.53$24.7M-51.4%+0.7%$-0.12-341.7%
2024-05-26Q4 FY20242024-08-26$-0.13$37.9M+90.2%+21.6%$-0.12-8.3%
2024-02-25Q3 FY20242024-08-09$0.42$35.7M+135.0%+34.5%$0.07+500.0%
2023-11-26Q2 FY20242024-08-09$0.39$30.1M+190.7%+37.9%$-0.23+269.6%
2023-08-27Q1 FY20242024-08-09$-0.35$24.5M+5.4%+3.4%$-0.37+5.4%
2023-05-28Q4 FY20232024-03-20$-1.32$31.1M+29.8%+10.8%$-0.13-915.4%
2023-02-26Q3 FY20232023-06-02$-1.20$26.5M-172.7%-50.0%$-0.04-2900.0%
2022-11-27Q2 FY20232023-03-16$-0.43$21.9M+66.9%-83.1%——
2022-08-28Q1 FY20232022-10-07$-0.37$23.7M-15.6%-81.6%$-0.13-184.6%
2022-05-29Q4 FY20222022-09-14$-1.88$28.1M-1780.0%-79.9%$-0.01-18700.0%
2022-02-28Q3 FY20222022-02-28$-0.44$53.1M-83.3%+90.9%$0.01-4500.0%
2022-02-27Q3 FY20222022-04-07$-0.46$35.2M-91.7%+26.7%——
2021-11-30Q2 FY20222021-11-30$-1.30$129.5M-188.9%-1.1%$-0.04-3150.0%
2021-11-28Q2 FY20222022-01-07$-1.31$25.6M-191.1%-80.4%——
2021-08-31Q1 FY20222022-02-28$-0.32$128.8M+15.8%-5.1%$-0.12-166.7%
2021-08-29Q1 FY20222021-10-05$-0.32$22.3M+15.8%-83.5%——
2021-05-31Q4 FY20212021-05-31$-0.10$139.8M+80.8%-10.4%$0.01-1638.5%
2021-05-30Q4 FY20212021-07-29$-0.03$44.9M+94.2%-71.2%——
2021-02-28Q3 FY20212021-04-08$-0.24$27.8M+38.5%-81.8%$-0.02-1428.7%
2020-11-30Q2 FY20212020-11-30$-0.45$130.9M-95.7%-8.2%$0.01-4600.0%
2020-11-29Q2 FY20212021-01-07$-0.40$23.8M-73.9%-83.3%——
2020-08-31Q1 FY20212021-02-28$-0.38$135.6M-137.5%-2.2%$-0.11-245.5%
2020-08-30Q1 FY20212020-10-07$-0.42$22.7M-162.5%-83.7%——
2020-05-31Q4 FY20202020-08-14$-0.52$156.1M-5100.0%+2.2%$0.03-1990.9%
2020-02-29Q3 FY20202020-02-29$-0.39$152.9M-143.8%+10.2%$0.03-1660.0%
2020-02-23Q3 FY20202020-04-03$-0.39$152.9M-143.8%+10.2%——
2019-11-30Q2 FY20202019-11-30$-0.23$142.6M-2200.0%-6.7%$-0.06-283.3%
2019-11-24Q2 FY20202020-01-02$-0.23$142.6M-2400.0%-6.7%——
2019-08-31Q1 FY20202020-02-29$-0.16$138.7M——$-0.160.0%
2019-08-25Q1 FY20202019-10-03$-0.16$138.7M————
2019-05-31Q4 FY20192019-05-31$-0.01$152.8M——$-0.01-66.7%
2019-05-26Q4 FY20192019-08-01$0.01$152.8M————
EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.